Andaman Medical

𝗠𝗲𝗲𝘁 𝗢𝘂𝗿 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁𝘀 🎬 Behind every smooth medical device launch in Southeast Asia is a dedicated team that turns complex government approvals into a clear, hassle-free path to market. 𝗪𝗵𝗲𝗻 𝗽𝗲𝗼𝗽𝗹𝗲 𝗵𝗲𝗮𝗿 "𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲”, 𝘁𝗵𝗲𝘆 𝗼𝗳𝘁𝗲𝗻 𝘁𝗵𝗶𝗻𝗸 𝗼𝗳 𝘀𝘁𝗿𝗶𝗰𝘁 𝗴𝗼𝘃𝗲𝗿𝗻𝗺𝗲𝗻𝘁 𝗿𝘂𝗹𝗲𝘀 𝗮𝗻𝗱 𝗲𝗻𝗱𝗹𝗲𝘀𝘀 𝘀𝘁𝗮𝗰𝗸𝘀 𝗼𝗳 𝗽𝗮𝗽𝗲𝗿𝘄𝗼𝗿𝗸 𝘁𝗵𝗮𝘁 𝘀𝗹𝗼𝘄 𝗲𝘃𝗲𝗿𝘆𝘁𝗵𝗶𝗻𝗴 𝗱𝗼𝘄𝗻. 𝗜𝗻 𝗽𝗹𝗮𝗶𝗻 𝘁𝗲𝗿𝗺𝘀, 𝗼𝘂𝗿 𝗷𝗼𝗯 𝗶𝘀 𝘀𝗶𝗺𝗽𝗹𝗲: 𝘄𝗲 𝗵𝗮𝗻𝗱𝗹𝗲 𝘁𝗵𝗲 𝗮𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝘃𝗲 𝗵𝗲𝗮𝘃𝘆 𝗹𝗶𝗳𝘁𝗶𝗻𝗴, 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹 𝗳𝗶𝗹𝗶𝗻𝗴𝘀, 𝗮𝗻𝗱 𝗵𝗲𝗮𝗹𝘁𝗵 𝗮𝘂𝘁𝗵𝗼𝗿𝗶𝘁𝘆 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝘀𝗼 𝗹𝗶𝗳𝗲-𝘀𝗮𝘃𝗶𝗻𝗴 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲𝘀 𝗿𝗲𝗮𝗰𝗵 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘀𝗮𝗳𝗲𝗹𝘆—𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗰𝗼𝘀𝘁𝗹𝘆 𝗱𝗲𝗹𝗮𝘆𝘀. Meet Aceline Tan PW and Nuraisyah Shukri, Senior Regulatory Affairs & Business Development Specialists at Andaman Medical! 👋 From device risk classification and dossier reviews to post-market surveillance and regional strategy across ASEAN markets, Aceline and Aisyah handle the technical complexities so our clients can focus on growing their business. Press play to meet the experts behind our regulatory operations and see how we help global MedTech innovators navigate market access! Have questions about ASEAN regulatory guidelines or upcoming compliance changes? Reach out to our team today! #MeetTheTeam #RegulatoryAffairs #MedTech #ASEANMarketAccess #MedicalDevices #LifeAtAndamanMedical #RegulatoryCompliance #RealExpertsRealGuidance

𝗘𝗻𝘁𝗲𝗿𝗶𝗻𝗴 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗦𝗼𝘂𝘁𝗵𝗲𝗮𝘀𝘁 𝗔𝘀𝗶𝗮𝗻 𝗺𝗮𝗿𝗸𝗲𝘁𝘀 𝗼𝗳𝘁𝗲𝗻 𝗺𝗲𝗮𝗻𝘀 𝗰𝗼𝗼𝗿𝗱𝗶𝗻𝗮𝘁𝗶𝗻𝗴 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀, 𝘁𝗶𝗺𝗲𝗹𝗶𝗻𝗲𝘀, 𝗮𝗻𝗱 𝗹𝗼𝗰𝗮𝗹 𝘀𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿𝘀. With Andaman Medical, manufacturers can manage their regional expansion through a single point of contact. Our in-house local teams provide coordinated support for product registration, local authorized representation, importation, and post-market compliance across the region. One regional partner. Local expertise in every market. Get in touch with us to discuss your Southeast Asia market access plans: https://lnkd.in/eBytckwq #AndamanMedical #MedicalDevices #MarketAccess #RegulatoryAffairs #SoutheastAsia #MedTech

𝗔𝗣𝗔𝗖 𝗶𝘀 𝗽𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝗺𝗼𝗿𝗲 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻. 𝗦𝗰𝗮𝗹𝗶𝗻𝗴 𝗶𝘁 𝗶𝘀 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲. According to Bain & Company, the region’s medical device market, excluding IVD and laboratory equipment, is projected to reach US$132 billion by 2030. Companies across APAC are also developing original technologies, conducting global clinical trials, and securing international approvals. However, a strong product does not automatically become a globally adopted one. Before entering new markets, manufacturers should assess whether they have: ✔️ Defined their priority markets ✔️ Planned the required clinical evidence ✔️ Built scalable regulatory and quality capabilities ✔️ Protected their intellectual property in key markets ✔️ Prepared their commercialization and health economics strategy Gaps in any of these areas can slow expansion, even when the underlying technology is ready. Planning early allows regulatory, clinical, and commercial decisions to support one another throughout product development. Expanding into Southeast Asia? Not sure whether your regulatory strategy is ready? Speak with Andaman Medical to assess your market-entry pathway: https://lnkd.in/eBytckwq #AndamanMedical #APACMedTech #MedicalDevices #MedTechInnovation #MarketAccess #RegulatoryAffairs #ClinicalEvidence #HealthcareInnovation Source: https://lnkd.in/gTzvEq7H